Viewing Study NCT04763434



Ignite Creation Date: 2024-05-06 @ 3:48 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04763434
Status: UNKNOWN
Last Update Posted: 2021-02-21
First Post: 2021-02-17

Brief Title: Dexamethasone and Dexmedetomidine as Adjuvants to Ropivacaine in Ultrasound-guided Multilevel Thoracic Paravertebral Block for Lobectomy A Prospective Randomized Triple-blind Study
Sponsor: Gansu Provincial Hospital
Organization: Gansu Provincial Hospital

Study Overview

Official Title: Dexamethasone and Dexmedetomidine as Adjuvants to Ropivacaine in Ultrasound-guided Multilevel Thoracic Paravertebral Block for Lobectomy A Prospective Randomized Triple-blind Study
Status: UNKNOWN
Status Verified Date: 2021-02
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The hypothesis is whether perineural dexamethasone and dexmedetomidine prolonged the duration of analgesia as compared with either perineural dexamethasone or perineural dexmedetomidine after TPVB
Detailed Description: Design A prospective randomized controlled study Setting Single-center university hospital Participants The study included 90 patients undergoing lobectomy under general anesthesia

Interventions The patients were allocated randomly into the following 3 groups 20 ml mixture of 375 mg ropivacaine with 5 mg dexamethasone RS group or 1 µgkg dexmedetomidine RM group or with 1 µgkg dexmedetomidine and 5 mg dexamethasone RSM group Ultrasound-guided TPVB was performed at 4 points-T4-5 T5-6 T6-7 and T7-8 of the surgical side 5 mL of solution were injected at each point Postoperatively the PCIA was used as part of multimodal analgesia and all patients recieve

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None